Navigation Links
Rules-Based Medicine, Inc. Names Tony Barnes to Lead Expanding Diagnostics Business
Date:6/2/2009

AUSTIN, Texas, June 2 /PRNewswire/ -- Rules-Based Medicine, Incorporated (RBM), the leading biomarker testing service, today announced that Tony Barnes, Ph.D., MBA, has joined the Company as vice president, clinical diagnostics. Barnes will provide strategic marketing and operational leadership as RBM commercializes new biomarker-based diagnostic tests.

RBM, an established provider of multiplex biomarker assays for improved drug development, has programs to develop new diagnostic products targeting disease categories that currently lack accurate and objective tests. Commercialization programs underway include tests for schizophrenia and kidney disease. The Company has access to interesting and novel biomarker technology through partnerships with multiple companies and institutions, including companion diagnostic programs with major pharmaceutical companies.

Barnes brings to the Company 25 years experience in business development, senior management, marketing, operations and program management, gained at leading healthcare companies, such as Abbott Diagnostics, LifeScan Inc., and Ciba Corning Diagnostics. He also served as a strategic consultant for Booz Allen and Hamilton and consulted directly to major healthcare companies such as Ortho Pharma and Bristol-Myers Squibb.

Most recently, Barnes served as co-founder, chief executive officer and vice chairman of Oncimmune Ltd. During his six years with the company, Barnes developed and managed comprehensive technical, marketing and operations plans for the company and led the establishment of both the U.K. parent and U.S. subsidiary businesses. The first Oncimmune product, EarlyCDT-Lung(TM), a test for the early detection of lung cancer was launched in May 2009.

"As we establish new processes and infrastructure around our diagnostic programs, the additive value of Tony's extensive development, marketing, and operational experience will only strengthen our effort," said Craig Benson, RBM chief executive officer. "We are pleased to have him on board and welcome his insight and energy."

"RBM is positioned to accelerate the development of exciting and necessary diagnostic tests," said Barnes. "The Company is on the leading edge of multiplex assay technology that has the potential to enhance patient care. I look forward to working with the RBM management team and our collaborators to advance that vision."

About Rules-Based Medicine, Inc.

Rules-Based Medicine (RBM) provides comprehensive protein biomarker products and services centered on its Multi-Analyte Profiling (MAP) technology. Its service platform (RodentMAP(R) and HumanMAP(R)) provides pre-clinical and clinical researchers with reproducible, quantitative, multiplexed immunoassay data for hundreds of proteins cost-effectively in multiple species, and from a small sample volume. The Company also offers innovative and proprietary ex vivo testing systems such as TruCulture(TM), the first fully-closed, reproducible whole blood culture system. RBM is actively developing multiplex diagnostic tests to detect the presence of complex diseases and conditions in areas of unmet medical need such as neuropsychiatry, nephrology, immunology and cardiology. More information about RBM is located at www.rbmmaps.com.

RodentMAP(R) and HumanMAP(R) are registered trademarks of Rules-Based Medicine Inc.


'/>"/>
SOURCE Rules-Based Medicine, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Hofstra University to Establish New School of Medicine, Partnering with the North Shore-LIJ Health System
2. Next Step(R) Institute of Integrative Medicine, Inc. Takes Wellness to a New Level With 2008 Series of Wellness Weeks
3. Tip sheet for the Annals of Internal Medicine, April 15, 2008, issue
4. Elsevier expands Procedures Consult with emergency medicine, orthopedics and anesthesia procedures
5. McGraw-Hill Professional Redesigns AccessMedicine, Highlighting Media and Educational Features
6. AMD Global Telemedicine, Inc. Forms Telemedicine Design Group
7. Healthcare Reform Should Include Connected Health and Participatory Medicine, Says Report Submitted to President Obama by Center for Connected Health
8. McGraw-Hill Professional and JAMA Launch New Online Evidence-Based Medicine, Clinical and Educational Resource
9. Local Infertility Specialist, Dr. Rachel Bennett, Westchester Reproductive Medicine, Opens New Office in Mount Kisco
10. AMD Global Telemedicine, Inc is Pleased to Announce the Selection of its Examination Camera for the Canadian National Telehealth Videoconference Equipment RFP
11. Penn Medicine, CHOP researchers demonstrate first common genetic risk factors for autism
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2016)... ... 2016 , ... Melanoma is the deadliest type of skin cancer. Although only about 1 percent ... cancer deaths. More than 10,000 people are expected to die of melanoma this year. The ... the one of the most commonly diagnosed cancers in young women. A recent breakthrough in ...
(Date:4/29/2016)... ... April 29, 2016 , ... Reltok Nasal Products proudly announces that Boston ... and neck/ear, nose and throat specialty, has added the KOTLER NASAL AIRWAY™ to its ... is a newly patented safety device secured by nasal surgeons onto the floor ...
(Date:4/29/2016)... ... April 29, 2016 , ... Innovations with Ed Begley ... upcoming episode, airing third quarter 2016 via Discovery Channel. Dates and show times ... Dairy Products, located in Greenwood, Wisconsin applies product research and development and continuous ...
(Date:4/29/2016)... ... April 29, 2016 , ... The infertility specialists at ... Sanaz Ghazal, and Dr. Daniel A. Potter -- are proud of the recent release ... Technology (SART). In April, SART published the latest verified data for 375 ...
(Date:4/29/2016)... ... April 29, 2016 , ... International Dehydrated Foods, Inc. (IDF™) will attend ... 4 at the Doubletree by Hilton Hotel in Oak Brook, Illinois. The two-day event ... technologies for protein ingredients. , At the seminar, IDF™ will offer samples of its ...
Breaking Medicine News(10 mins):
(Date:4/28/2016)... 28, 2016  Marking its one year anniversary ... ovarian cancer risk test, Color Genomics ... that highly impact the most common hereditary cancers ... Color Test analyzes hereditary cancer risks for breast, ... cancers. The Color Test is physician ordered and ...
(Date:4/28/2016)... YORK , April 28, 2016  The blood ... 275 million dollars, according to Kalorama Information and The ... typing, immunoassays and nucleic acid testing.  The healthcare research ... made progress in developing blood collection stations and in ... made in Kalorama Information,s report, Blood Testing ...
(Date:4/28/2016)... WARSAW, Ind., April 28, 2016 , Net ... a reported basis over the prior year period, and an ... basis , Diluted EPS for the first quarter were ... period, and $2.00 adjusted, an increase of 29.9% over the ... revenue and adjusted earnings guidance for 2016 Zimmer ...
Breaking Medicine Technology: